Cysview is a medication used in the diagnosis and treatment of bladder cancer. It is a sterile solution that contains hexaminolevulinate, a chemical that is activated by blue light and helps to identify cancerous cells in the bladder.

When Cysview is instilled into the bladder, it is absorbed by the cancerous cells and causes them to fluoresce under blue light. This fluorescence allows healthcare providers to more accurately identify and remove cancerous tissue during procedures such as cystoscopy.

Cysview is typically used in conjunction with cystoscopy, a procedure in which a thin tube with a camera is inserted into the bladder to examine the lining for abnormalities. By using Cysview during cystoscopy, healthcare providers can better visualize and target cancerous cells, leading to more effective treatment outcomes.

It is important to note that Cysview is not a treatment for bladder cancer on its own, but rather a tool to aid in the diagnosis and treatment of the disease. It is generally well-tolerated, with minimal side effects such as bladder irritation or discomfort during urination.

If you have been diagnosed with bladder cancer or are at risk for the disease, talk to your healthcare provider about whether Cysview may be a beneficial addition to your treatment plan. They can provide more information on how Cysview works and whether it is appropriate for your specific situation. Remember, early detection and treatment are key in improving outcomes for bladder cancer patients.